Literature DB >> 6848374

Activation and regulation of the first complement component.

N R Cooper.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6848374

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


× No keyword cloud information.
  9 in total

1.  Characterization of C1 inhibitor binding to neutrophils.

Authors:  N S Chang; R J Boackle; R W Leu
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

Review 2.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

Review 3.  The chemistry and biology of complement receptors.

Authors:  R D Schreiber
Journal:  Springer Semin Immunopathol       Date:  1984

4.  Activation of the alternative and classical complement pathways by Entamoeba histolytica.

Authors:  J Calderon; R D Schreiber
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

5.  Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A.

Authors:  S W Vukajlovich
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

6.  Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns.

Authors:  G Pluschke; M Achtman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

7.  C1q, a subunit of the first component of complement, enhances binding of plasma fibronectin to bacteria.

Authors:  J M Sorvillo; E Pearlstein
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

Review 8.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

9.  C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro.

Authors:  F A Robey; K D Jones; A D Steinberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.